Table 1 |
|||||
| Effects of the methanol extract from C. zeylanicum on lipid profile in L-NAME hypertensive rats | |||||
| Treatment | Triglycerides (mg/dl) | Total cholesterol (mg/dl) | HDL-cholesterol (mg/dl) | LDL-cholesterol (mg/dl) | Atherogenic index |
| Control | 53.48 ± 3.36 | 50.63 ± 2.07 | 48.76 ± 3.13 | 5.51 ± 3.68 | 1.06 ± 0.31 |
| L-NAME | 81.10 ± 3.80β | 83.13 ± 4.02γ | 17.57 ± 2.82β | 38.52 ± 4.29β | 5.35 ± 0.48γ |
| L-N + Capto | 45.74 ± 3.36** | 48.12 ± 2.09*** | 40.40 ± 3.32** | 4.50 ± 3.96*** | 1.50 ± 0.70*** |
| L-N + MECZ | 50.16 ± 3.33* | 56.46 ± 5.29*** | 42.26 ± 3.83** | 9.50 ± 3.08*** | 1.41 ± 0.18*** |
n = 5; βp < 0.01 and γp < 0.001 significantly different compared to the control; *p < 0.05, **p < 0.01 and ***p < 0.001 significantly different compared to L-NAME. L-NAME group received only L-NAME 40 mg/kg/day. L-N + Capto received L-NAME plus captopril (20 mg/kg/day) while L-N + MECZ received L-NAME plus extract (300 mg/kg/day).
Nyadjeu et al. BMC Complementary and Alternative Medicine 2013 13:27 doi:10.1186/1472-6882-13-27
